1. Home
  2. Labeler Index
  3. Zydus Pharmaceuticals (usa) Inc.
  4. 70710-2054
  5. NDC Package Code: 70710-2054-3 Deflazacort

NDC Package 70710-2054-3 Deflazacort

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70710-2054-3
Package Description:
1 BOTTLE in 1 CARTON / 30 TABLET in 1 BOTTLE
Product Code:
70710-2054
Proprietary Name:
Deflazacort
Non-Proprietary Name:
Deflazacort
Substance Name:
Deflazacort
Usage Information:
 Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.Additional pediatric use information is approved for PTC Therapeutics, Inc.'s Emflaza™ (deflazacort) tablets. However, due to PTC Therapeutics, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information.
11-Digit NDC Billing Format:
70710205403
Product Type:
Human Prescription Drug
Labeler Name:
Zydus Pharmaceuticals (usa) Inc.
Dosage Form:
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
DEFLAZACORT 36 mg/1
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA219254
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
06-12-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70710-2054-3?

The NDC Packaged Code 70710-2054-3 is assigned to a package of 1 bottle in 1 carton / 30 tablet in 1 bottle of Deflazacort, a human prescription drug labeled by Zydus Pharmaceuticals (usa) Inc.. The product's dosage form is tablet and is administered via oral form.

Is NDC 70710-2054 included in the NDC Directory?

Yes, Deflazacort with product code 70710-2054 is active and included in the NDC Directory. The product was first marketed by Zydus Pharmaceuticals (usa) Inc. on June 12, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70710-2054-3?

The 11-digit format is 70710205403. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-170710-2054-35-4-270710-2054-03